NEW YORK, Jan. 27, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) between November 2, 2023 and October 30, 2024, both dates...
Read More Details
Finally We wish PressBee provided you with enough information of ( REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit )
Also on site :
- Walmart Is Selling a 'Fantastic' $400 Charcoal Smoker Grill for Just $110, and Shoppers Say It's 'Perfect for Tailgating and Picnics'
- Orlando Bloom Spotted With Kim Kardashian Amid Katy Perry Split Rumors
- 'General Hospital' Legend, 62, Makes Rare Red Carpet Appearance To Honor Late Co-Star